Abbott Laboratories
XMUN:ABL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbott Laboratories
XMUN:ABL
|
US |
|
M
|
Meta Platforms Inc
XMUN:FB2A
|
US |
|
A
|
Aluminum Corporation of China Ltd
XMUN:AOC
|
CN |
|
H
|
Hartford Financial Services Group Inc
DUS:HFF
|
US |
|
MINISO Group Holding Ltd
F:MIF0
|
CN |
|
B
|
Boeing Co
XMUN:BCO
|
US |
|
C
|
Cadence Design Systems Inc
XMUN:CDS
|
US |
|
CleanGo Innovations Inc
F:APO
|
CA |
|
I
|
Industria de Diseno Textil SA
MIL:ITX
|
ES |
|
C
|
Chefs' Warehouse Inc
F:2CF
|
US |
|
S
|
Siauliu Bankas AB
XMUN:ZH5
|
LT |
|
P
|
Pernod Ricard SA
XMUN:PER
|
FR |
|
B
|
BYD Co Ltd
XMUN:BY6
|
CN |
|
W
|
Waste Management Inc
F:UWS
|
US |
|
Telefonica SA
MIL:TEF
|
ES |
Wall St Price Targets
ABL Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for ABL is 102.46 EUR with a low forecast of 78.01 EUR and a high forecast of 126.05 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABL's stock price target?
Price Target
102.46
EUR
According to Wall Street analysts, the average 1-year price target for ABL is 102.46 EUR with a low forecast of 78.01 EUR and a high forecast of 126.05 EUR.
What is the Revenue forecast for Abbott Laboratories?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 7 years is 9%.
What is the Operating Income forecast for Abbott Laboratories?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 7 years is 14%.
What is the Net Income forecast for Abbott Laboratories?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 7 years is 15%.
